XML 23 R27.htm IDEA: XBRL DOCUMENT v2.4.0.8
Transactions with Olympus Corporation (Tables)
9 Months Ended
Sep. 30, 2013
Transactions with Olympus Corporation [Abstract]  
Schedule of Acquired Intangible Assets
The fair value of the Joint Venture, including the identified intangible assets acquired, consideration transferred, and Cytori’s previously held equity interest, was estimated from a market participant perspective, using valuation techniques based on the income approach for measuring fair value.  Specifically, an excess earnings methodology was employed using primarily Level 3 fair value inputs.  The intangible assets acquired consisted primarily of contractual license rights that had previously enabled the Joint Venture to conduct development and manufacturing activities pertaining to certain aspects of Cytori’s Celution ® technology.  The useful life of the identifiable intangible assets was estimated based on the assumed future economic benefit expected to be received from the assets.  Inputs used in the valuation included various market participant assumptions in order to project potential future cash flows, discounted at a rate commensurate with the risk involved.

 
 
 
Useful Life
(in years)
  
Estimated
Fair Value
 
Intangible assets:
 
  
 
Developed technology
  
7
  
$
9,394,000
 
Schedule of Assets Acquired and Liabilities Assumed
The following table summarizes the fair value of the assets acquired and liabilities assumed at the date of acquisition (in thousands):

 
 
Estimated
Fair Value
 
Current assets
 
$
236
 
Property and equipment
  
260
 
Intangible assets
  
9,394
 
 
    
Total assets acquired
  
9,890
 
 
    
Accrued and other current liabilities
  
(33
)
Total fair value of the Joint Venture
 
$
9,857